Cargando…
Resveratrol provides benefits in mice with type II diabetes-induced chronic renal failure through AMPK signaling pathway
Type II diabetes-induced ischemic injuries are known to lead to the rapid degeneration of the kidneys as a result of chronic renal failure. Chronic renal failure is a condition, which typically manifests with symptoms including cardiovascular system and left ventricular hypertrophy, atherosclerosis...
Autores principales: | Guo, Haiyan, Zhang, Linyun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5995082/ https://www.ncbi.nlm.nih.gov/pubmed/29896258 http://dx.doi.org/10.3892/etm.2018.6178 |
Ejemplares similares
-
Resveratrol, novel application by preconditioning to attenuate myocardial ischemia/reperfusion injury in mice through regulate AMPK pathway and autophagy level
por: Li, Haiyan, et al.
Publicado: (2022) -
Resveratrol relieves gestational diabetes mellitus in mice through activating AMPK
por: Yao, Liangqi, et al.
Publicado: (2015) -
Synergistic antitumor effect of resveratrol and sorafenib on hepatocellular carcinoma through PKA/AMPK/eEF2K pathway
por: Gao, Meili, et al.
Publicado: (2021) -
Resveratrol enhances GLUT-4 translocation to the caveolar lipid raft fractions through AMPK/Akt/eNOS signalling pathway in diabetic myocardium
por: Penumathsa, S Varma, et al.
Publicado: (2010) -
Resveratrol enhances GLUT-4 translocation to the caveolar lipid raft fractions through AMPK/Akt/eNOS signalling pathway in diabetic myocardium
por: Penumathsa, S Varma, et al.
Publicado: (2008)